In OSCC, pharmacologic or genetic inhibition of the PI3K/AKT/mTOR cascade effectively suppresses tumor-cell proliferation, invasion, and metastatic dissemination [11,12,13]. The gene discussed is MTOR; the disease is neoplasm.